Heterocyclic derivatives as platelet aggregation inhibitors

Details Heterocyclic derivatives as platelet aggregation inhibitors Heterocyclic derivatives as platelet aggregation inhibitors

C - Chemistry, Metallurgy

07

D

C07D 401/04 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) C07D 213/74 (2006.01) C07D 417/04 (2006.01) C07D 471/04 (2006.01) C07D 491/052 (2006.01)

Patent

CA 2156070

Compounds of formula (I) and metabolically labile esters and amides thereof, and pharmaceutically acceptable salts thereof in which R13, M2, Xi, Z1, Z1, X2 and A1 have the meanings given in the specification. The compounds are useful as inhibitors of the binding of fibrinogen to glycoprotein IIb/IIIa. Novel intermediates are also disclosed.

Affiliated with

Also associated with

Rating

Heterocyclic derivatives as platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic derivatives as platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as platelet aggregation inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2088081